Equities

Eli Lilly and Co

0Q1G:LSE

Eli Lilly and Co

  • Price (CHF)0.00
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 20 minutes, as of Dec 30 1899.
More ▼

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue34,12428,54128,318
OPERATING EXPENSES
Cost of revenue total7,0826,6307,313
Selling, general and admin. expenses, total7,4036,4406,432
Depreciation/amortization------
Unusual expense(income)3,8681,1531,596
Other operating expenses, total------
Total operating expense27,66621,41422,367
Operating income6,4587,1275,952
Other, net429359341
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes6,5556,8066,156
Provision for income taxes1,314562574
Net income after taxes5,2406,2455,582
Minority interest------
Net income before extra. Items5,2406,2455,582
Total extraordinary items----0
Net income5,2406,2455,582
Inc.avail. to common excl. extra. Items5,2406,2455,582
Inc.avail. to common incl. extra. Items5,2406,2455,582
EPS RECONCILIATION
Basic/primary weighted average shares900902907
Basic/primary eps excl. extra items5.826.936.15
Basic/primary eps incl. extra items5.826.936.15
Dilution adjustment------
Diluted weighted average shares903905912
Diluted eps excl. extra items5.806.906.12
Diluted eps incl. extra items5.806.906.12
COMMON STOCK DIVIDENDS
DPS - common stock primary issue4.523.923.40
Gross dividend - common stock4,2213,6683,202
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental486332340
SUPPLEMENTAL INCOME
Depreciation, supplemental1,022943919
Total special items3,8681,1531,596
NORMALISED INCOME
Normalized income before taxes10,4227,9607,752
Effect of special items on income taxes142067
Income tax excluding impact of special items1,328582641
Normalized income after tax9,0947,3787,111
Normalized income avail. to common9,0947,3787,111
Basic normalized EPS108.187.84
Diluted normalized EPS108.167.80
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.